TransMedica withdraws patent lawsuit:
This article was originally published in Clinica
Cell Robotics' defence of a patent infringement suit around its Lasette laser finger perforator for glucose testing has ended successfully. Privately-owned TransMedica, formerly Venisect, has withdrawn its federal lawsuit begun last year. The Albuquerque-based Cell Robotics said that it was satisfied with the decision, although it acknowledged that TransMedica could bring the suit back again in a different court.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.